BACKGROUND: The causes of elevated B-Type natriuretic peptide (BNP) levels are multifactorial. Renal dysfunction has been shown to affect BNP levels in some studies and the diagnostic value of BNP levels in the presence of chronic kidney disease has been questioned. Prior studies have involved small patient populations with variable outcomes noted. This study evaluated the association of BNP levels with an estimated glomerular filtration rate (eGFR) and presence or absence of congestive heart failure (CHF). METHODS: A retrospective, cross-sectional study in which medical records were electronically screened, identified patients with a BNP level and serum creatinine measurement on the same day between December 2002 and March 2006. RESULTS: Of 1739 eligible patients, 537 were positive for CHF and 1202 were negative for CHF by our criteria. There was a clear trend for BNP to be higher with the advancement of CHF, as determined by New York Heart Association (NYHA) classification (P<0.001). Median BNP levels increased from 65 pg/mL in patients without CHF to 496 pg/mL in patients with NYHA class IV CHF (P <0.001), and there was a strong inverse association with eGFR (P <0.001). CONCLUSION: BNP levels show a strong inverse association with eGFR in both CHF and non-CHF patients. Currently best practice at most institutions involves use of BNP cutoff diagnostic levels not adjusted for eGFR. The data presented underlines that eGFR is a significant confounder of BNP measurement especially when renal status is compromised and interpretation of clinical significance in the presence of elevated BNP measures should take renal status into consideration.
BACKGROUND: The causes of elevated B-Type natriuretic peptide (BNP) levels are multifactorial. Renal dysfunction has been shown to affect BNP levels in some studies and the diagnostic value of BNP levels in the presence of chronic kidney disease has been questioned. Prior studies have involved small patient populations with variable outcomes noted. This study evaluated the association of BNP levels with an estimated glomerular filtration rate (eGFR) and presence or absence of congestive heart failure (CHF). METHODS: A retrospective, cross-sectional study in which medical records were electronically screened, identified patients with a BNP level and serum creatinine measurement on the same day between December 2002 and March 2006. RESULTS: Of 1739 eligible patients, 537 were positive for CHF and 1202 were negative for CHF by our criteria. There was a clear trend for BNP to be higher with the advancement of CHF, as determined by New York Heart Association (NYHA) classification (P<0.001). Median BNP levels increased from 65 pg/mL in patients without CHF to 496 pg/mL in patients with NYHA class IV CHF (P <0.001), and there was a strong inverse association with eGFR (P <0.001). CONCLUSION:BNP levels show a strong inverse association with eGFR in both CHF and non-CHFpatients. Currently best practice at most institutions involves use of BNP cutoff diagnostic levels not adjusted for eGFR. The data presented underlines that eGFR is a significant confounder of BNP measurement especially when renal status is compromised and interpretation of clinical significance in the presence of elevated BNP measures should take renal status into consideration.
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente Journal: Ann Intern Med Date: 2006-08-15 Impact factor: 25.391
Authors: Russell A Wilke; Richard L Berg; Peggy Peissig; Terrie Kitchner; Bozana Sijercic; Catherine A McCarty; Daniel J McCarty Journal: Clin Med Res Date: 2007-03
Authors: Mark E Davis; A Mark Richards; M Gary Nicholls; Timothy G Yandle; Christopher M Frampton; Richard W Troughton Journal: Circulation Date: 2006-02-13 Impact factor: 29.690
Authors: Patrick Jourdain; Guillaume Jondeau; François Funck; Pascal Gueffet; Alain Le Helloco; Erwan Donal; Jean F Aupetit; Marie C Aumont; Michel Galinier; Jean C Eicher; Alain Cohen-Solal; Yves Juillière Journal: J Am Coll Cardiol Date: 2007-04-02 Impact factor: 24.094
Authors: Marc Vanderheyden; Jozef Bartunek; Gerasimos Filippatos; Marc Goethals; Bruno Van Vlem; Alan Maisel Journal: Congest Heart Fail Date: 2008 Jul-Aug
Authors: Jae Won Yang; Min Soo Kim; Jae Seok Kim; Jong Myoung Yoo; Seung Tae Han; Bi Ro Kim; Yun Deok Kim; Jeong Wook Choi; Seung Ok Choi; Byoung Geun Han Journal: Korean J Intern Med Date: 2008-12 Impact factor: 2.884
Authors: Derek J Bivona; Srikar Tallavajhala; Mohamad Abdi; Pim J A Oomen; Xu Gao; Rohit Malhotra; Andrew Darby; Oliver J Monfredi; J Michael Mangrum; Pamela Mason; Sula Mazimba; Michael Salerno; Christopher M Kramer; Frederick H Epstein; Jeffrey W Holmes; Kenneth C Bilchick Journal: Front Cardiovasc Med Date: 2022-09-15
Authors: Wendy Ying; Di Zhao; Pamela Ouyang; Vinita Subramanya; Dhananjay Vaidya; Chiadi E Ndumele; Eliseo Guallar; Kavita Sharma; Sanjiv J Shah; David A Kass; Ron C Hoogeveen; Joao A Lima; Susan R Heckbert; Christopher R deFilippi; Wendy S Post; Erin D Michos Journal: J Am Heart Assoc Date: 2019-12-16 Impact factor: 5.501